MA29220B1 - Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci - Google Patents

Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci

Info

Publication number
MA29220B1
MA29220B1 MA29957A MA29957A MA29220B1 MA 29220 B1 MA29220 B1 MA 29220B1 MA 29957 A MA29957 A MA 29957A MA 29957 A MA29957 A MA 29957A MA 29220 B1 MA29220 B1 MA 29220B1
Authority
MA
Morocco
Prior art keywords
skin
loss
androgenes
treat
administration
Prior art date
Application number
MA29957A
Other languages
English (en)
Inventor
Mohamed El-Alfy
Fernand Labrie
Lamia Azzi
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorech Inc filed Critical Endorech Inc
Publication of MA29220B1 publication Critical patent/MA29220B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

LA PRÉSENTE INVENTION SE RAPPORTE À DE NOUVEAUX PROCÉDÉS PERMETTANT DE TRAITER OU DE RETARDER LES PROBLÈMES CUTANÉS DUS À UNE CARENCE EN ANDROGÈNES LIÉE À L'ÂGE, NOTAMMENT UNE ATROPHIE CUTANÉE, UNE PERTE DE COLLAGÈNE, UNE PERTE DE FIBRES ÉLASTIQUES, UNE PERTE DE TISSU CONJONCTIF, DE LA CELLULITE, ET LA FORMATION DE RIDES, CHEZ DES ANIMAUX À SANG CHAUD SENSIBLES TELS QUE LES HUMAINS, CES PROCÉDÉS CONSISTANT EN L'ADMINISTRATION D'UN ANDROGÈNE ET/OU D'UN PRÉCURSEUR DE STÉROÏDE SEXUEL. L'INVENTION SE RAPPORTE ÉGALEMENT À DES COMPOSITIONS PHARMACEUTIQUES PERMETTANT L'ADMINISTRATION D'UN OU DE PLUSIEURS PRINCIPES ACTIFS UTILES POUR LA MISE EN OEUVRE DE CES PROCÉDÉS.
MA29957A 2004-11-01 2007-05-30 Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci MA29220B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01

Publications (1)

Publication Number Publication Date
MA29220B1 true MA29220B1 (fr) 2008-02-01

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29957A MA29220B1 (fr) 2004-11-01 2007-05-30 Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci

Country Status (20)

Country Link
US (1) US20060178352A1 (fr)
EP (1) EP1807062A4 (fr)
JP (1) JP2008517952A (fr)
KR (1) KR20070073964A (fr)
CN (1) CN101094676A (fr)
AP (1) AP2007003982A0 (fr)
AU (1) AU2005301035A1 (fr)
BR (1) BRPI0517950A (fr)
CA (1) CA2585666A1 (fr)
EA (1) EA200700983A1 (fr)
GE (1) GEP20094833B (fr)
HR (1) HRP20070183A2 (fr)
IL (1) IL182844A0 (fr)
MA (1) MA29220B1 (fr)
MX (1) MX2007005098A (fr)
NO (1) NO20072642L (fr)
RS (1) RS20070185A (fr)
TN (1) TNSN07163A1 (fr)
WO (1) WO2006047859A1 (fr)
ZA (1) ZA200703531B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106038572A (zh) 2004-10-20 2016-10-26 恩多研究公司 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
US8269380B2 (en) 2006-06-01 2012-09-18 Panasonic Corporation Brushless motor for washing machine having stress reduction on sensor casing and washing machine having the brushless motor mounted therein
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
WO2015055179A1 (fr) * 2013-10-15 2015-04-23 Chelac Holding Gmbh Esters d'acide stéroïde-carboxylique, compositions contenant des esters d'acide stéroïde-carboxylique et leur utilisation dans une application localement topique à des fins cosmétiques ou dermatologiques
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法
US12426782B2 (en) 2020-11-06 2025-09-30 The Board Of Trustees Of The Leland Stanford Junior University Systems and temporal alignment methods for evaluation of gestational age and time to delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE531437A (fr) * 1953-08-26
PT1382340E (pt) * 1993-01-19 2006-07-31 Endorech Inc Utilizacoes terapeuticas de desidroepiandrosterona para tratar libido diminuida e osteoporose
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
NZ536787A (en) * 1998-06-11 2006-03-31 Endorech Inc Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
CN101094676A (zh) 2007-12-26
WO2006047859A1 (fr) 2006-05-11
EP1807062A1 (fr) 2007-07-18
AU2005301035A1 (en) 2006-05-11
EA200700983A1 (ru) 2008-04-28
KR20070073964A (ko) 2007-07-10
BRPI0517950A (pt) 2008-10-21
JP2008517952A (ja) 2008-05-29
MX2007005098A (es) 2008-01-16
RS20070185A (sr) 2008-09-29
HRP20070183A2 (en) 2007-08-31
AP2007003982A0 (en) 2007-06-30
TNSN07163A1 (en) 2008-11-21
IL182844A0 (en) 2007-09-20
GEP20094833B (en) 2009-11-25
NO20072642L (no) 2007-07-30
CA2585666A1 (fr) 2006-05-11
EP1807062A4 (fr) 2009-06-03
US20060178352A1 (en) 2006-08-10
ZA200703531B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
TR200002784T2 (tr) Tip 5 ve tip 3 17beta-Hidroksisteroid dehidrojenaz inhibitörleri ve bunların kullanımı için metodlar
EA200870393A1 (ru) Новые композиции для нарушений волос и способ получения композиций
MX2009001323A (es) Aposito solido para tratar tejido herido.
AU6769701A (en) Sprayable wound care compositions
EP2175726A4 (fr) Compositions comprenant des amplificateurs de la dégradation des récepteurs de l'androgène (ard) et procédés de traitement prophylactique ou thérapeutique de troubles cutanés et de la chute des cheveux
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
DE50007706D1 (de) Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
ATE398993T1 (de) Zusammensetzungen zur behandlung von zahn- und/oder knochengewebe
WO2008112773A3 (fr) Droxidopa et composition pharmaceutique de celle-ci pour le traitement de l'hypotension véhiculée par voie neurale
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
PL1863430T3 (pl) Kompozycja oparta na ekstraktach roślinnych z Ajuga reptans do zapobiegania utracie włosów, pobudzania wzrostu włosów i regulacji wytwarzania łoju skórnego
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
WO2002064088A3 (fr) Composition pharmaceutique permettant le traitement de l'alopecie
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
EP1272177A4 (fr) Methode et formulation permettant de traiter une resistance aux antihypertenseurs et des affections associees
TNSN07163A1 (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
ATE445409T1 (de) Zusammensetzungen mit matrixproteinen zur regeneration von dentin
BR9908713A (pt) Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
DE60005952D1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
WO2008043938A3 (fr) Composition comprenant au moins un composé générateur d'oxygène actif, et au moins un agent épaississant, procédé pour sa préparation et son utilisation en cosmétique et en hygiène dentaire
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion